Orladeyo gains approval in Brazil for HAE prevention
A product of BioCryst Pharmaceuticals, Orladeyo’s registration, commercialisation and distribution are solely handled by Pint Pharma in Latin America. Hereditary angioedema (HAE) is a genetic disorder characterised by